FOXC2 (forkhead box C2) is a transcription factor that plays critical roles in development and disease pathogenesis. As a member of the FOX gene family, FOXC2 functions as a transcriptional activator involved in embryonic development, particularly in angiogenesis and lymphangiogenesis 1. The protein regulates multiple cellular processes through sequence-specific DNA binding and transcriptional activation. In cancer biology, FOXC2 promotes tumor progression through several mechanisms, including vasculogenic mimicry where it drives ectopic expression of endothelial genes in tumor cells under hypoxic conditions, enabling formation of tumor-derived vascular networks that confer resistance to anti-angiogenic therapy 2. Meta-analysis demonstrates that increased FOXC2 expression correlates with poor overall survival, lymph node metastases, and advanced TNM staging across multiple solid tumor types 3. FOXC2 also contributes to hepatic fibrosis through matrix stiffness-induced activation of hepatic stellate cells into myofibroblasts 4. In ovarian cancer, FOXC2 promotes metastasis, lipid metabolism, and cisplatin resistance via the ITGB6 signaling axis 5. Beyond cancer, FOXC2 plays emerging roles in bone regeneration and osteogenesis, particularly in mesenchymal stem cell differentiation and osteoblast maturation 6. The gene is associated with lymphedema-distichiasis syndrome, reflecting its developmental importance in lymphatic system formation.